Dry AMD Expansion PineCone Vision Center recently launched FDA-authorized Valeda Light therapy for dry macular degeneration, signaling an opportunity to cross-sell complementary vision care services, treatment packages, and ongoing follow-up programs to patients and insurers seeking advanced therapies.

Integrated Care With a full-service ophthalmology practice coveringchildren to seniors and glaucoma screening, there is potential to upsell premium vision products, co-management for surgical procedures, and bundled preventive care plans to existing patients and through referral networks.

Tech Savvy Adoption of modern digital tools (Google Ads, WordPress, Gravity Forms, Google Cloud) suggests readiness for targeted marketing, patient acquisition campaigns, telehealth options, and online appointment scheduling to grow patient volume.

Insurance Ready Acceptance of all major insurance carriers and health spending accounts creates opportunities to offer value-based care packages, flexible financing for elective procedures, and partnerships with employer plans to drive patient inflow.

Mid-market Growth Revenue in the $1M–$10M range and 11–50 employees place PineCone as a scalable regional player. There is potential to assist with practice management, CRM enhancements, patient retention programs, and performance marketing to accelerate growth.